Aurora Spine Corporation develops and distributes minimally invasive interspinous fusion systems in Canada. Key strengths include a solid gross margin of 60.1%, indicating effective cost management, and a healthy current ratio of 2.25, suggesting good liquidity. However, concerns arise from negative EBITDA and net margins, reflecting ongoing operational losses, and a high debt-to-equity ratio of 1.23, which may indicate financial risk. The combination of high margins with low valuation could suggest potential for improvement, but current financial health requires careful monitoring.
Loading financial metrics...
Debt of $3.5M is 9.6x the company's cash position of $363K.
Exceptional gross margin of 61.6% indicates strong pricing power and competitive moat.
Operating cash flow grew 15.8% YoY, demonstrating improving cash conversion.
Low debt-to-revenue ratio of 19.9% indicates conservative financial management.
Strong liquidity position with current ratio of 2.2x.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical - Devices companies of a similar size
Based on 2026-Q2 (June 30, 2026)